Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/23723556.2016.1199265 http://scihub22266oqcxt.onion/10.1080/23723556.2016.1199265 C5068183!5068183!27857970     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Mol+Cell+Oncol 2016 ; 3 (5): ä Nephropedia Template TP {{tp|p=27857970|t=2016. BORA-dependent PLK1 regulation: A new weapon for cancer therapy?|pdf=|usr=}}{{27857970}} gab.com Text BORA-dependent PLK1 regulation: A new weapon for cancer therapy JO: Mol Cell Oncol http://www.kidney.de/pget.php?&tw=1&pmid=27857970 #FOAvip The mitotic kinase polo like kinase 1 (PLK1) is overexpressed in many cancers and its inhibition slows down proliferation and increases apoptosis in cancer cell lines. Understanding how PLK1 is activated is therefore crucial for the development of novel PLK1 inhibitors with anticancer properties. We recently identified a conserved regulatory loop leading to PLK1 activation that involves cyclin-dependent kinase 1 (CDK1). Twit Text FOAVip BORA-dependent PLK1 regulation: A new weapon for cancer therapy ????Mol Cell Oncol http://www.kidney.de/pget.php?&tw=1&pmid=27857970 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27857970 #FOAvip English Wikipedia <ref>{{Cite pmid|27857970}}</ref> BORA-dependent PLK1 regulation: A new weapon for cancer therapy? #MMPMID27857970 Cirillo L; Thomas Y; Pintard L; Gotta M Mol Cell Oncol 2016[]; 3 (5): ä PMID27857970show ga The mitotic kinase polo like kinase 1 (PLK1) is overexpressed in many cancers and its inhibition slows down proliferation and increases apoptosis in cancer cell lines. Understanding how PLK1 is activated is therefore crucial for the development of novel PLK1 inhibitors with anticancer properties. We recently identified a conserved regulatory loop leading to PLK1 activation that involves cyclin-dependent kinase 1 (CDK1). äBORA-dependent PLK1 regulation: A new weapon for cancer therapy?(epmc).pdf DeepDyve Pubget Overpricing